Search Results - "Klijn, JG"

The common sense model of self-regulation and psychological adjustment to predictive genetic testing: a prospective study by van Oostrom, Iris, Meijers-Heijboer, Hanne, Duivenvoorden, Hugo J., Bröcker-Vriends, Annette H. J. T., van Asperen, Christi J., Sijmons, Rolf H., Seynaeve, Caroline, Van Gool, Arthur R., Klijn, Jan G. M., Tibben, Aad

“…This prospective study explored the contribution of illness representations and coping to cancer‐related distress in unaffected individuals undergoing…”
Get full text

Trends in endocrine therapy and chemotherapy for early breast cancer : a focus on the premenopausal patient by JONAT, W, PRITCHARD, K. I, SAINSBURY, R, KLIJN, J. G

“…The majority of breast cancers are diagnosed at an early stage, and treatment is focused on cure and prolonging disease-free survival. Local therapy (surgery…”
Get full text

Genome-wide scanning for linkage in 56 Dutch breast cancer families selected for a minimal probability of being due to BRCA1 or BRCA2 by Oldenburg, RA, Kroeze-Jansema, K, Houwing, JJ, Kraan, J, Klijn, JG, Hoogerbrugge, N, Ligtenberg, MJ, van Asperen, CJ, Vasen, HF, Meijers-Heijboer, H, Cornelisse, CJ, Devilee, P

Get full text

Somatostatin receptors in differentiated ovarian tumors by Reubi, JC, Horisberger, U, Klijn, JG, Foekens, JA

“…The presence of somatostatin receptors was investigated in 57 primary human ovarian tumors using in vitro receptor autoradiography with three different…”
Get full text

Growth factor-receptor pathway interfering treatment by somatostatin analogs and suramin: preclinical and clinical studies by Klijn, J G, Setyono-Han, B, Bakker, G H, van der Burg, M E, Bontenbal, M, Peters, H A, Sieuwerts, A M, Berns, P M, Foekens, J A

“…Interference in growth factor mediated pathways is a new strategy in the treatment of cancer. Somatostatin analogs can inhibit hormone and growth factor…”
Get more information

The value of the thyrotropin-releasing hormone test in patients with prolactin-secreting pituitary tumors and suprasellar non-pituitary tumors by Klijn, J G, Lamberts, S W, de Jong, F H, Birkenhäger, J C

“…The prolactin (PRL) response to thyrotropin-releasing hormone (TRH) (delta PRL) was normal in 7 (18%) of 38 patients with clinical evidence of a prolactinoma…”
Get more information